On October 2, 2023, the Board of Directors of FibroGen, Inc. appointed Interim Chief Executive Officer Thane Wettig as Chief Executive Officer. Mr. Wettig held the position of Interim Chief Executive Officer since July 23, 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.135 USD | +9.13% | -0.88% | +27.50% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.50% | 103M | |
+2.09% | 42.75B | |
+47.70% | 41.61B | |
+11.69% | 41.34B | |
-12.36% | 26.59B | |
+8.29% | 25.49B | |
-23.03% | 18.12B | |
+30.85% | 12.24B | |
-1.44% | 11.76B | |
+8.47% | 11B |
- Stock Market
- Equities
- FGEN Stock
- News FibroGen, Inc.
- FibroGen, Inc. Appoints Thane Wettig as Chief Executive Officer